Literature DB >> 17145898

Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine.

Gang Lu1, Jie Liao, Guangyu Yang, Kenneth R Reuhl, Xingpei Hao, Chung S Yang.   

Abstract

The present study investigated the inhibitory effects of Polyphenon E [a standardized green tea polyphenol preparation containing 65% (-)-epigallocatechin-3-gallate] and caffeine on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumor progression from adenoma to adenocarcinoma. Female A/J mice were treated with a single dose of NNK (103 mg/kg body weight, i.p.) and kept for 20 weeks for the mice to develop lung adenomas. The mice were then given a solution of 0.5% Polyphenon E or 0.044% caffeine as the sole source of drinking fluid until week 52. Both treatments significantly decreased the number of visible lung tumors. Histopathologic analysis indicated that Polyphenon E administration significantly reduced the incidence (by 52%) and multiplicity (by 63%) of lung adenocarcinoma. Caffeine also showed marginal inhibitory effects in incidence and multiplicity of adenocarcinoma (by 48% and 49%, respectively). Markers of cell proliferation, apoptosis, and related cell signaling were studied by immunohistochemistry, and the labeling index and staining intensity were quantified by the Image-Pro system. Polyphenon E and caffeine treatment inhibited cell proliferation (by 57% and 50%, respectively) in adenocarcinomas, enhanced apoptosis in adenocarcinomas (by 2.6- and 4-fold, respectively) and adenomas (both by 2.5-fold), and lowered levels of c-Jun and extracellular signal-regulated kinase (Erk) 1/2 phosphorylation. In the normal lung tissues, neither agent had a significant effect on cell proliferation or apoptosis. The results show that tea polyphenols (and perhaps caffeine) inhibit the progression of NNK-induced lung adenoma to adenocarcinoma. This effect is closely associated with decreased cell proliferation, enhanced apoptosis, and lowered levels of c-Jun and Erk1/2 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145898     DOI: 10.1158/0008-5472.CAN-06-1497

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  56 in total

1.  Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy.

Authors:  G Zhang; Y Wang; Y Zhang; X Wan; J Li; K Liu; F Wang; K Liu; Q Liu; C Yang; P Yu; Y Huang; S Wang; P Jiang; Z Qu; J Luan; H Duan; L Zhang; A Hou; S Jin; T-C Hsieh; E Wu
Journal:  Curr Mol Med       Date:  2012-02       Impact factor: 2.222

Review 2.  Dietary agents for prevention and treatment of lung cancer.

Authors:  Naghma Khan; Hasan Mukhtar
Journal:  Cancer Lett       Date:  2015-01-30       Impact factor: 8.679

Review 3.  Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Authors:  Jaewon Lee; Dong-Gyu Jo; Daeui Park; Hae Young Chung; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

4.  Sustained systemic delivery of green tea polyphenols by polymeric implants significantly diminishes benzo[a]pyrene-induced DNA adducts.

Authors:  Pengxiao Cao; Manicka V Vadhanam; Wendy A Spencer; Jian Cai; Ramesh C Gupta
Journal:  Chem Res Toxicol       Date:  2011-05-31       Impact factor: 3.739

5.  Green tea inhibits cycolooxygenase-2 in non-small cell lung cancer cells through the induction of Annexin-1.

Authors:  Qing-Yi Lu; Yusheng Jin; Jenny T Mao; Zuo-Feng Zhang; David Heber; Steven M Dubinett; Jianyu Rao
Journal:  Biochem Biophys Res Commun       Date:  2012-10-02       Impact factor: 3.575

6.  In vivo detection of a novel endogenous etheno-DNA adduct derived from arachidonic acid and the effects of antioxidants on its formation.

Authors:  Ying Fu; Raghu G Nath; Marcin Dyba; Idalia M Cruz; Sharanya R Pondicherry; Aileen Fernandez; Casey L Schultz; Peiying Yang; Jishen Pan; Dhimant Desai; Jacek Krzeminski; Shantu Amin; Plamen P Christov; Yukihiko Hara; Fung-Lung Chung
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

7.  Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2.

Authors:  Vera Ivanova; Olga B Garbuzenko; Kenneth R Reuhl; David C Reimer; Vitaly P Pozharov; Tamara Minko
Journal:  Eur J Pharm Biopharm       Date:  2012-12-08       Impact factor: 5.571

8.  Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice.

Authors:  Junya Fujimoto; Humam Kadara; Taoyan Men; Carolyn van Pelt; Dafna Lotan; Reuben Lotan
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

Review 9.  Cancer prevention by tea and tea polyphenols.

Authors:  Chung S Yang; Jihyeung Ju; Gary Lu; Hang Xiao; Xingpei Hao; Shengmin Sang; Joshua D Lambert
Journal:  Asia Pac J Clin Nutr       Date:  2008       Impact factor: 1.662

10.  Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice.

Authors:  Fekadu Kassie; Stephen Kalscheuer; Ilze Matise; Linan Ma; Tamene Melkamu; Pramod Upadhyaya; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2009-07-22       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.